Literature DB >> 6894487

Thrombocytopenia: first symptom in a patient with dyskeratosis congenita.

K De Boeck, H Degreef, R Verwilghen, L Corbeel, M Casteels-Van Daele.   

Abstract

A case of dyskeratosis congenita is reported. This rare hereditary disease usually has the following progression: ectodermal dystrophy (reticular skin pigmentation, nail dystrophy, leukokeratosis of mucosal membranes), appearing in the first decade, followed in about 50% of these patients by a hematopoietic disorder resembling Fanconi's anemia, usually developing in the second or third decade. Carcinomas may occur in leukokeratotic areas in the third, fourth, or fifth decade. This patient's clinical course is interesting because the thrombocytopenia developed as an isolated symptom at the age of 5 years and preceded the skin anomalies by three years. The diagnosis of dyskeratosis congenita was made only after an evolution of five years. The diagnosis of dyskeratosis congenita--although it is a rare disease--should be considered in every child first seen with aplastic anemia or thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894487

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita.

Authors:  K Devriendt; G Matthijs; E Legius; E Schollen; D Blockmans; C van Geet; H Degreef; J J Cassiman; J P Fryns
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation.

Authors:  Mukand Lal; Manoj Thakur; Sandeep Kashyap
Journal:  Indian J Hematol Blood Transfus       Date:  2015-02-07       Impact factor: 0.900

3.  Vitreous hemorrhage secondary to retinal vasculopathy in a patient with dyskeratosis congenita.

Authors:  Alessandro Finzi; Mariachiara Morara; Francesco Pichi; Chiara Veronese; Antonio P Ciardella
Journal:  Int Ophthalmol       Date:  2013-10-10       Impact factor: 2.031

4.  Clastogen-induced fragility may differentiate pancytopenia of congenital dyskeratosis from Fanconi anaemia.

Authors:  A Schneider; U Mayer; E Gebhart; D Harms; J Gromball; U Glöckel; J D Beck
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Dyskeratosis congenita- management and review of complications: a case report.

Authors:  Shivam Sinha; Vikas Trivedi; Arvind Krishna; Nidhi Rao
Journal:  Oman Med J       Date:  2013-07

6.  Hereditary sclerosing poikiloderma.

Authors:  Hyo Jin Lee; Dong Hoon Shin; Jong Soo Choi; Ki Hong Kim
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.